首页> 外文期刊>Cardiovascular Research >Non-cardiomyocyte microRNAs in heart failure
【24h】

Non-cardiomyocyte microRNAs in heart failure

机译:心力衰竭中的非心肌细胞microRNA

获取原文
获取原文并翻译 | 示例
           

摘要

Multiple structural changes are known to occur in a failing heart. Myocyte hypertrophy, cardiomyocyte apoptosis, interstitial fibrosis, reduced capillary density, and activation of the immune system are all involved in the pathogenesis and progression of heart failure (HF). The molecular mechanisms underlying these changes of the myocardium have been extensively studied, and many pathways involved in these processes have been uncovered. Recently, it has become evident that a novel class of small non-coding RNAs, called miRNAs, also plays a key role in these structural changes of the heart. This review summarizes the current insights on the role of miRNAs outside myocytes in the heart. Specifically, we will discuss miRNA function in fibroblasts, endothelial cells and immune cells in response to myocardial stress as occurs after myocardial infarction and in the pathogenesis of HF.
机译:已知心脏衰竭会发生多种结构变化。心肌细胞肥大,心肌细胞凋亡,间质纤维化,毛细血管密度降低和免疫系统激活均与心力衰竭(HF)的发病机理和进展有关。心肌这些变化的分子机制已得到广泛研究,并且涉及这些过程的许多途径也已被发现。最近,很明显,一类新型的小型非编码RNA(称为miRNA)在心脏的这些结构变化中也起着关键作用。这篇综述总结了关于心肌中心肌细胞外miRNA作用的最新见解。具体来说,我们将讨论在心肌梗塞后和HF发病过程中发生的心肌应激反应中,成纤维细胞,内皮细胞和免疫细胞中的miRNA功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号